ALNY icon

Alnylam Pharmaceuticals

418 hedge funds and large institutions have $16.5B invested in Alnylam Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 131 increasing their positions, 159 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

18% less repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 159

21% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 68

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

Holders
418
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$486M
Puts
$346M
Net Calls
Net Calls Change

Top Buyers

1 +$626M
2 +$238M
3 +$90.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$48.6M
5
Morgan Stanley
Morgan Stanley
New York
+$40.8M

Top Sellers

1 -$251M
2 -$178M
3 -$131M
4
Invesco
Invesco
Georgia
-$117M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$92.7M
Name Holding Trade Value Shares
Change
Change in
Stake
226
$885K
227
$865K
228
$855K
229
$834K
230
$809K
231
$808K
232
$791K
233
$786K
234
$772K
235
$767K
236
$738K
237
$729K
238
$729K
239
$729K
240
$728K
241
$709K
242
$708K
243
$707K
244
$699K
245
$689K
246
$685K
247
$672K
248
$667K
249
$663K
250
$662K